---
created: 2025-04-13
updated: 2025-04-13T10:52
id: u-v5F;?7pe
specialty: neuro
specialty_id: 191
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::15-neuro::07-other::02-seizures
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::01-epilepsy-therapy
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::01-epilepsy-therapy::valproic-acid
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::11-pediatrics::19-seizures
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::14-neuro::02-epilepsy-lamotrigine,-levetiracetam,-topiramate-and-valproic-acid
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::13-antiepileptics::valproic-acid-(valproate)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::06-neuro/psych::04-mood-stabilizers-&-antiepileptic-drugs::03-valproate,-topiramate,-lamotrigine,-levetiracetam
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - "source/ak-step2-v11:": 
  - theme/b&b::04-neuro::02-seziures::seizures-treatment"
type: flashcard
---

# Question
Valproic acid exerts its effects by increasing **Na+** channel **inactivation** and inhibiting **GABA transaminase**

---

# Answer
